Form 4: ClearPoint Neuro CFO Sells Shares to Cover Tax Obligations

Danilo D'Alessandro, CFO of ClearPoint Neuro, sold 1,191 shares of common stock on August 20, 2024, to cover tax withholding obligations related to vesting restricted stock.

Summary

• On August 20, 2024, Danilo D'Alessandro, the Chief Financial Officer of ClearPoint Neuro, Inc., disposed of 1,191 shares of common stock.
• The transaction was executed to satisfy tax withholding obligations associated with the vesting of restricted stock.
• The shares were sold at a price of $11.26 per share.
• Following the transaction, D'Alessandro directly owns 49,492 shares of ClearPoint Neuro, Inc.

Sentiment

Score: 5

Explanation: This is a neutral event. The sale is related to tax obligations, not necessarily an indication of the CFO's sentiment about the company's future prospects.

Industry Context

Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. This transaction is related to tax obligations, which is a common reason for insider sales.

Stakeholder Impact

• The sale of shares by an insider could have a minor negative impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates